Clinical Trials in San Diego

Showing 1841-1860 of 12,589 trials

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

NCT06777901

The goal of this clinical trial is to learn if the Auryon Atherectomy System with balloon angioplasty safe and effective in treating lower limb blockages. The main question it aims to answer is: Is treatment with Auryon Atherectomy System more effective than angioplasty alone in preventing death, amputation, revascularization and improving patency? Researchers will compare the Auryon Atherectomy System with balloon angioplasty to balloon angioplasty alone.

Peripheral Arterial Diseases

Angiodynamics, Inc.224 participantsStarted Apr 2025

Phoenix, Arizona, United States • San Diego, California, United States • Gray, Louisiana, United States +6 more locations

COMPLETEDPhase 1< 1 mile

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

NCT06130722

First-in-Human, Phase I, open-label, multicenter, dose-escalation study to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary antitumor activity of FL115 in patients with advanced solid tumors who have progressed or are intolerant to current standard-of-care therapies, including immune check-point inhibitors administered in single-agent or combination use.

Locally Advanced/Metastatic Solid Tumors

Suzhou Forlong Biotechnology Co., Ltd18 participantsStarted Dec 2023

Newport Beach, California, United States • San Diego, California, United States • Canton, Ohio, United States

Auryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty Alone

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

Find Trials by Condition in San Diego

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

Integrated Health Care for PTSD

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

A Study of CT-388 in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

[18F]PI-2620 Phase 3 Histopathological Study

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Molgramostim Nebulizer Solution Expanded Access Program Protocol

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.